1. Home
  2. PL vs MDXG Comparison

PL vs MDXG Comparison

Compare PL & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PL
  • MDXG
  • Stock Information
  • Founded
  • PL 2010
  • MDXG 2006
  • Country
  • PL United States
  • MDXG United States
  • Employees
  • PL N/A
  • MDXG N/A
  • Industry
  • PL Aerospace
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • PL Industrials
  • MDXG Health Care
  • Exchange
  • PL Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • PL 1.0B
  • MDXG 1.2B
  • IPO Year
  • PL N/A
  • MDXG N/A
  • Fundamental
  • Price
  • PL $3.44
  • MDXG $7.54
  • Analyst Decision
  • PL Strong Buy
  • MDXG Strong Buy
  • Analyst Count
  • PL 11
  • MDXG 3
  • Target Price
  • PL $5.79
  • MDXG $12.00
  • AVG Volume (30 Days)
  • PL 4.7M
  • MDXG 580.4K
  • Earning Date
  • PL 03-20-2025
  • MDXG 04-29-2025
  • Dividend Yield
  • PL N/A
  • MDXG N/A
  • EPS Growth
  • PL N/A
  • MDXG N/A
  • EPS
  • PL N/A
  • MDXG 0.28
  • Revenue
  • PL $244,352,000.00
  • MDXG $348,879,000.00
  • Revenue This Year
  • PL $15.78
  • MDXG $10.09
  • Revenue Next Year
  • PL $17.22
  • MDXG $11.77
  • P/E Ratio
  • PL N/A
  • MDXG $26.64
  • Revenue Growth
  • PL 10.72
  • MDXG 8.52
  • 52 Week Low
  • PL $1.67
  • MDXG $5.47
  • 52 Week High
  • PL $6.71
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • PL 37.38
  • MDXG 36.94
  • Support Level
  • PL $3.15
  • MDXG $7.84
  • Resistance Level
  • PL $4.03
  • MDXG $8.12
  • Average True Range (ATR)
  • PL 0.25
  • MDXG 0.26
  • MACD
  • PL -0.00
  • MDXG -0.02
  • Stochastic Oscillator
  • PL 41.78
  • MDXG 7.69

About PL Planet Labs PBC

Planet Labs PBC is an Earth-imaging company. The company provides daily satellite data that helps businesses, governments, researchers, and journalists understand the physical world and take action.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: